Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. - Wikidata - awgldk - TriplyDB

Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors.

Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors.

http://www.wikidata.org/entity/Q34152088

about

MHC class I multimers Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers Phenotypic analysis of antigen-specific T lymphocytes Why can't cytotoxic T cells handle HIV?A comparison of elasticities of viral levels to specific immune response mechanisms in human immunodeficiency virus infection.Differential remodeling of a T-cell transcriptome following CD8- versus CD3-induced signaling.Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy.Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation.Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression.Memory CD8+ T cells in HIV infection Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression.Cellular immune responses to HIV.Development of immunotherapeutic strategies for HIV-1.Detection and quantification of HIV-1 specific CD4 helper and CD8 cytotoxic cells: their role in HIV-1-infected individuals and vaccine recipients.The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes.High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention.HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression.Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy.T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules.Direct ex vivo analysis of activated, Fas-sensitive autoreactive T cells in human autoimmune disease.Upregulation of Fas ligand by simian immunodeficiency virus - a nef-arious mechanism of immune evasion?HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor.Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex.Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines.Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses.A whole blood monokine-based reporter assay provides a sensitive and robust measurement of the antigen-specific T cell response.Angiocentric CD3(+) T-cell infiltrates in human immunodeficiency virus type 1-associated central nervous system disease in children.Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.

P2860

Q24805668-C77332BC-8CE5-49C6-A3A9-090842149866 Q27649766-C86821DD-72D4-4762-878F-CC08AFE753E0 Q28290058-26159EA9-F7C7-4381-8EFA-2E686C767446 Q30453955-54CFA112-0D9D-4774-B9EE-999777CBEFC9 Q30596957-20EF3845-CF1B-4F5C-B6D7-C818A1B2795A Q33334064-58DDCC15-9189-4EB2-99D8-09F924E94B08 Q33648533-3F08F595-6497-41FF-9FBB-8781D2504538 Q33799802-33A109CD-BE0F-4BE9-A93B-535983E06A76 Q33809451-1327A3D2-C99E-4BF7-9662-79F65E06C4E0 Q33841686-506ED604-85DE-4B00-BCB0-C7BEAF7B9356 Q33905214-909D803F-D878-47E6-ABCC-F1661D7A4468 Q34059524-DB254130-2750-4190-B518-F2A62EC3669E Q34223069-CC4E5B67-2145-4DC4-A390-E588C035BF3D Q34452629-00237B04-B2F9-40EF-950B-73490B0D54A4 Q34459401-59F463A7-79A9-493F-B30A-038FBA5E6DDB Q34999197-84AADD4F-89F8-4E98-8742-FBB990317699 Q35192655-D68B1455-ACE3-4CE9-B7BB-2644A36FB396 Q35613792-72B4B4C6-BB14-4A4C-8753-8A128895361F Q35834664-384AC404-86DA-4A13-93A9-67AB2C0020E3 Q35857259-48436994-A242-43BA-9DA1-2D175EB3BD5E Q35881271-8ADFB0F2-6E13-4177-B4E6-BAE2A8BA5364 Q36092837-76E4920E-D64D-47D2-AD82-97D636541857 Q36366511-C9AAA10C-FE1E-438E-B2EE-E83CE25528F1 Q36376216-586ED4C0-EA65-479F-A233-E829A22E0DD2 Q36377062-4B8DF15F-AC4B-4996-ABDE-562ED506D9C5 Q36377160-F71FAC23-8532-4189-B156-7518A4B11877 Q36380283-D4B7E3C9-2C2A-4965-A7FC-BDBEB5A9E0CD Q36399832-A19FD531-B32D-425A-977F-BBCD1EFECAA1 Q36400759-7285847D-54A2-41B6-BA83-5E7D9D81D22C Q36498251-97CBA9C3-F020-41AB-AFC4-C0A2F8C55996 Q36524157-D7AEC246-0BE1-412A-8E1C-EB9AF059A2E3 Q36720991-8DB2C61B-78EC-47DA-B790-DACBDC581485 Q37059723-87DA693A-D4AD-40B4-B086-2F5DB9D5406B Q37193564-86137A79-2B78-44DF-96B6-5E191F0E5EA1 Q37202298-B7AE00DB-110D-4A54-8E87-81C9F8166734 Q37511451-9E3BE143-2218-4E85-A912-C5B815A4F81D Q38086432-718F0489-D073-4936-9472-851E7A277A71 Q38557856-258A439A-8F42-4F50-878A-EBF718FE34C8 Q39506140-0AA549D8-9E54-493A-9130-E33F9D9A120D Q39549058-08961DE7-2383-40BA-9814-7B6828213784

P2860

Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors.

http://www.wikidata.org/entity/Q34152088

description

1995 nî lūn-bûn

@nan

1995 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Persistent high frequency of h ...... eral blood of infected donors.

@ast

Persistent high frequency of h ...... eral blood of infected donors.

@en

Persistent high frequency of h ...... eral blood of infected donors.

@nl

type

label

Persistent high frequency of h ...... eral blood of infected donors.

@ast

Persistent high frequency of h ...... eral blood of infected donors.

@en

Persistent high frequency of h ...... eral blood of infected donors.

@nl

prefLabel

Persistent high frequency of h ...... eral blood of infected donors.

@ast

Persistent high frequency of h ...... eral blood of infected donors.

@en

Persistent high frequency of h ...... eral blood of infected donors.

@nl

P1433

Q34152088-0F9A3750-AE3B-4667-8B5F-19EBE60B2BFF

P1476

Q34152088-DD0F8A48-179A-4D92-A146-D41B0EED753C

P2093

Q34152088-0C8343A5-2029-4978-9795-D332429775C9

Q34152088-2BC62380-E5A8-4196-B0CB-2B558532E7F2

Q34152088-3DCEAD6A-87E9-4FAC-A2BA-217995F47924

Q34152088-6722C01F-DF3F-492D-88D4-B3C610A0BADC

Q34152088-68E27FA2-2AB7-424E-8FA5-F682799D1ED5

Q34152088-738BD455-1054-4D89-A56C-7BF3D94D6959

Q34152088-E10EDAE9-0CEB-414E-AF6B-68BE792D3C3D

P2860

Q34152088-0A7E7EFF-5BE3-4222-92A7-B80DF09EE867

Q34152088-2A2926CA-2FD0-4B37-81BC-6B0A8BC1ED4B

Q34152088-2AD27186-05AB-4106-9F86-642E672C7B84

Q34152088-2CDA4FED-6DB9-47ED-995F-A73A60C9C784

Q34152088-315674C9-2493-45EF-8883-39827D49EC51

Q34152088-3B010247-8F5C-4438-8C85-9BCBE8031F6E

Q34152088-44DE29AC-82EA-4263-8C90-D5129A0B7E5F

Q34152088-491E5EA8-061D-45D4-9EC8-7B9D8615CB12

Q34152088-5F1725E6-50AF-4E4E-8BBA-C5A8192B8F4F

Q34152088-70BB6970-ED12-47FF-BC19-BE5D132B5D71

P304

Q34152088-457CDBD5-5837-41E2-93D2-C60AEAC9C0CA

P31

Q34152088-B78BB424-7599-41B7-9614-DF3F36D49F96

P356

Q34152088-5121C286-76B5-4679-AC33-C360D910F01C

P407

Q34152088-9AD757F6-7EAA-43B3-9EA7-BE763A87F0FE

P433

Q34152088-E2C4D421-ED66-483F-8470-44AAC259C7C6

P478

Q34152088-8D8868BB-1545-4AB5-A285-4FCF557183F7

P577

Q34152088-5C02ACE7-9298-4A47-B08B-6B32E0EC8D8C

P5875

Q34152088-67A14B91-A192-43A5-B3EC-CD0254FE92F2

P698

Q34152088-A8CBBA3F-FF61-4008-A03E-07D5DD8EDC7E

P921

Q34152088-C6197E67-9CC9-4CC8-9268-3CD0205EC83B

P932

Q34152088-DF50727F-A83D-4D5D-B62E-2192CEA1E02A

P356

PNAS.92.13.5773

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Persistent high frequency of h ...... eral blood of infected donors.

@en

P2093

A J McMichael

http://www.w3.org/2001/XMLSchema#string

J I Bell

http://www.w3.org/2001/XMLSchema#string

P A Moss

http://www.w3.org/2001/XMLSchema#string

P Giangrande

http://www.w3.org/2001/XMLSchema#string

P M Frodsham

http://www.w3.org/2001/XMLSchema#string

S L Rowland-Jones

http://www.w3.org/2001/XMLSchema#string

S McAdam

http://www.w3.org/2001/XMLSchema#string

P2860

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire

In vivo clonal dominance and limited T-cell receptor usage in human CD4+ T-cell recognition of house dust mite allergens.

Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins.

Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide

An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein.

Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families.

AIDS virus-specific cytotoxic T lymphocytes in lung disorders.

P304

5773-5777

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.92.13.5773

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

1995-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15602169

http://www.w3.org/2001/XMLSchema#string

P698

7597028

http://www.w3.org/2001/XMLSchema#string

P921

P932

41583

http://www.w3.org/2001/XMLSchema#string